Pharvaris (PHVS) Share-based Compensation Growth (1y) (2021 - 2026)
Pharvaris (PHVS) Share-based Compensation Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Stock Comp. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
-69.95% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
0.18% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Pharvaris |
28.66 Bn |
28.37 Bn |
- |
32.07% |
| Date | Value |
|---|
| Mar 31, 2026 |
32.07% |
| Dec 31, 2025 |
2.16% |
| Sep 30, 2025 |
-62.94% |
| Jun 30, 2025 |
60.89% |
| Mar 31, 2025 |
66.48% |
| Dec 31, 2024 |
93.92% |
| Sep 30, 2024 |
-19.70% |
| Jun 30, 2024 |
17.34% |
| Mar 31, 2024 |
-5.92% |
| Dec 31, 2023 |
-18.73% |
| Sep 30, 2023 |
-187,987,220.43% |
| Jun 30, 2023 |
172,087,079.47% |
| Mar 31, 2023 |
26.87% |
| Dec 31, 2022 |
44.18% |
| Sep 30, 2022 |
11.31% |
| Jun 30, 2022 |
57.09% |
| Mar 31, 2022 |
-13.60% |
| Dec 31, 2021 |
255.19% |
| Sep 30, 2021 |
504.78% |
| Jun 30, 2021 |
428.96% |
